98%
921
2 minutes
20
Genes encoding the opioid receptors (OPRM1, OPRD1 and OPRK1) are obvious candidates for involvement in risk for heroin dependence. Prior association studies commonly had samples of modest size, included limited single nucleotide polymorphism (SNP) coverage of these genes and yielded inconsistent results. Participants for the current investigation included 1459 heroin-dependent cases ascertained from maintenance clinics in New South Wales, Australia, 1495 unrelated individuals selected from an Australian sample of twins and siblings as not meeting DSM-IV criteria for lifetime alcohol or illicit drug dependence (non-dependent controls) and 531 controls ascertained from economically disadvantaged neighborhoods in proximity to the maintenance clinics. A total of 136 OPRM1, OPRD1 and OPRK1 SNPs were genotyped in this sample. After controlling for admixture with principal components analysis, our comparison of cases to non-dependent controls found four OPRD1 SNPs in fairly high linkage disequilibrium for which adjusted P values remained significant (e.g. rs2236857; OR 1.25; P=2.95×10(-4) ) replicating a previously reported association. A post hoc analysis revealed that the two SNP (rs2236857 and rs581111) GA haplotype in OPRD1 is associated with greater risk (OR 1.68; P=1.41×10(-5) ). No OPRM1 or OPRK1 SNPs reached more than nominal significance. Comparisons of cases to neighborhood controls reached only nominal significance. Our results replicate a prior report providing strong evidence implicating OPRD1 SNPs and, in particular, the two SNP (rs2236857 and rs581111) GA haplotype in liability for heroin dependence. Support was not found for similar association involving either OPRM1 or OPRK1 SNPs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867542 | PMC |
http://dx.doi.org/10.1111/j.1369-1600.2012.00445.x | DOI Listing |
J Psychoactive Drugs
September 2025
Former Senior Research Officer, Laboratory, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
Opioid use disrupts the hypothalamic-pituitary-adrenal (HPA) axis, altering stress responses depending on the stage of use. A higher cortisol/DHEA-S ratio may indicate relapse risk in substance use disorders. This study aimed to explore differences in serum cortisol/DHEA-S ratio and its association with proximal and perceived stress, social support, and coping strategies in opioid-dependent youth.
View Article and Find Full Text PDFPsychol Med
August 2025
Department of Radiology, https://ror.org/00ms48f15Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Background: Methadone maintenance treatment (MMT) and protracted abstinence (PA) effectively reduce the craving for heroin among individuals with heroin use disorder (HUD). However, the difference in their effects on brain function, especially the coupling among the large-scale brain networks (default mode [DMN], salience [SN], and executive control [ECN] networks), remains unclear. This study analyzed the effects of the MMT and PA on these networks and the predictive value of the bilateral resource allocation index (RAI) for craving for heroin.
View Article and Find Full Text PDFAddict Behav
August 2025
Johns Hopkins Bloomberg School of Public Health, Center for Indigenous Health, United States.
We describe stages of opioid and psychostimulant use (i.e., onset of use and progression to dependence) over the early life course within Indigenous communities where drug overdose impacts have been most extreme.
View Article and Find Full Text PDFJAMA Netw Open
August 2025
Division of Alcohol, Drugs and Addiction, McLean Hospital, Belmont, Massachusetts.
Importance: Several large, randomized clinical trials have tested the efficacy of adding behavioral therapy to medical management (high-quality, low-intensity medical counseling) and buprenorphine treatment of opioid use disorder. These studies have consistently reported strong rates of treatment response overall, without a significant additive benefit of additional behavioral therapy.
Objective: To address gaps in knowledge about additional behavioral therapy for patients receiving buprenorphine, including the association of additional behavioral therapy with retention and functional outcomes, and whether certain subgroups respond better to additional behavioral therapy.
J Subst Use Addict Treat
October 2025
The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Camperdown, NSW, Australia.
Introduction: Cross-sectional studies have shown a well-established relationship between post-traumatic stress disorder (PTSD) and substance use disorders, particularly, heroin dependence. The present study examines the prevalence, correlates and predictors of PTSD over the longer term among people with a history of heroin dependence.
Method: This study explored PTSD outcomes at the 18-20-year follow-up of the Australian Treatment Outcomes Study, a prospective longitudinal study of 615 people with heroin dependence recruited from Sydney, Australia in 2001-2002.